GLP-1s and Obesity Cancers; Cannabis’ New Legal Status; Celebrity Cancer Diagnoses

MedPage Today) — GLP-1 agonists may have little impact on risk of obesity-related cancers, according to a systematic review and meta-analysis of randomized studies. (Annals of Internal Medicine)
The FDA granted accelerated approval for the subcutaneous…
Read More